Health & Environmental Research Online (HERO)


Print Feedback Export to File
3857402 
Journal Article 
In vitro metabolism of 8-2 fluorotelomer alcohol: interspecies comparisons and metabolic pathway refinement 
Nabb, DL; Szostek, B; Himmelstein, MW; Mawn, MP; Gargas, ML; Sweeney, LM; Stadler, JC; Buck, RC; Fasano, WJ 
2007 
Toxicological Sciences
ISSN: 1096-6080
EISSN: 1096-0929 
OXFORD UNIV PRESS 
OXFORD 
100 
333-344 
English 
The detection of perfluorinated organic compounds in the environment has generated interest in their biological fate. 8-2 Fluorotelomer alcohol (8-2 FTOH, C(7)F(15)CF(2)CH(2)CH(2)OH), a raw material used in the manufacture of fluorotelomer-based products, has been identified in the environment and has been implicated as a potential source for perfluorooctanoic acid (PFOA) in the environment. In this study, the in vitro metabolism of [3-(14)C] 8-2 FTOH and selected acid metabolites by rat, mouse, trout, and human hepatocytes and by rat, mouse, and human liver microsomes and cytosol were investigated. Clearance rates of 8-2 FTOH in hepatocytes indicated rat > mouse > human >/= trout. A number of metabolites not previously reported were identified, adding further understanding to the pathway for 8-2 FTOH metabolism. Neither perfluorooctanoate nor perfluorononanoate was detected from incubations with human microsomes. To further elucidate the steps in the metabolic pathway, hepatocytes were incubated with 8-2 fluorotelomer acid, 8-2 fluorotelomer unsaturated acid, 7-3 acid, 7-3 unsaturated acid, and 7-2 secondary fluorotelomer alcohol. Shorter chain perfluorinated acids were only observed in hepatocyte and microsome incubations of the 8-2 acids but not from the 7-3 acids. Overall, the results indicate that 8-2 FTOH is extensively metabolized in rats and mice and to a lesser extent in humans and trout. Metabolism of 8-2 FTOH to perfluorinated acids was extremely small and likely mediated by enzymes in the microsomal fraction. These results suggest that human exposure to 8-2 FTOH is not expected to be a significant source of PFOA or any other perfluorocarboxylic acids. 
8-2 fluorotelomer alcohol; glutathione conjugates; taurine conjugates; perfluorinated carboxylic acids; perfluorooctanoate; perfluorononanoic acid; fluorotelomer aldehydes; hepatocytes; hepatic clearance; microsomes 
• Additional PFAS (formerly XAgency)
• Expanded PFAS SEM (formerly PFAS 430)
     Litsearch: September 2019
          PubMed
     Not prioritized for screening
     Potassium perfluorooctanoate
     Sodium perfluorooctanoate
     3:2 Fluorotelomer alcohol
• FtOH 8:2
     Literature Search
          Pubmed
          WOS
     Screening Results
          Toxicokinetic studies
               ADME
• ^Per- and Polyfluoroalkyl Substances (PFAS)
     PFNA (375-95-1)
          Literature Search
               Pubmed
               WOS
     FtOH 8:2 (678-39-7)
          Literature Search
               Pubmed
               WOS
• PFAS 150
     Literature Search Update December 2020
          PubMed
     Literature Search August 2019
          PubMed
          Web of Science
          Other sources
               Reference list review of included studies
     Screened Studies
          Included
               Include (TIAB)
          Supplemental
     7:3 Fluorotelomer alcohol
     8:2 Fluorotelomer alcohol
     Ammonium perfluorooctanoate
     Perfluorononanoic acid
     Perfluorooctanoic acid
• PFBA
     Protocol References
• PFHxA
     Title and Abstract Screening
          Tagged as Supplemental
               ADME TK
     HAWC
• PFNA
     Literature Search (August 2017)
          Pubmed
     Litsearch Addl Synonyms 2018
          WOS
     PFNA Literature Search pre-2019
          Pubmed
          WOS
     Literature Search
          Pubmed
          WOS
     Screening Results
          Excluded/Not on Topic
     Title and Abstract Screening
          Excluded
               Not relevant to PECO
• Yale PFAS Liver study